PATFORD HOUSE PARTNERSHIP — All Prescriptions & Medications — Page 7
Practice Code: J83050 | CALNE, SN11 0EF
Showing results 301-350 of 608
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Melatonin | 80 | 6,058 | £2.1K | -75.9% ▼ |
| Clonidine hydrochloride | 80 | 12.8K | £1.3K | +50.0% ▲ |
| Phenytoin sodium | 80 | 6,881 | £1.0K | -0.9% vs avg |
| Powder 1.6 kcal/ml milkshake (0913011) | 79 | 3,258 | £1.7K | +6.0% ▲ |
| Brivaracetam | 78 | 8,380 | £11.4K | +129.3% ▲ |
| Norethisterone | 78 | 4,878 | £758 | +60.8% ▲ |
| Medroxyprogesterone acetate | 77 | 4,792 | £733 | +101.2% ▲ |
| Nitrazepam | 76 | 7,984 | £15.8K | +46.3% ▲ |
| Carbomer 940/980 | 75 | 1,260 | £199 | -50.7% ▼ |
| Terbinafine hydrochloride | 75 | 2,100 | £379 | +102.1% ▲ |
| 75 | 563 | £49 | +151.1% ▲ | |
| Hydrocortisone | 74 | 5,010 | £1.5K | -12.4% ▼ |
| Risedronate sodium | 74 | 652 | £292 | -39.0% ▼ |
| Mycophenolate mofetil | 74 | 9,648 | £3.2K | +82.8% ▲ |
| Amiodarone hydrochloride | 72 | 2,261 | £126 | +11.6% ▲ |
| Bezafibrate | 72 | 4,364 | £909 | +33.7% ▲ |
| 71 | 9,120 | £16.1K | +45.7% ▲ | |
| Midodrine hydrochloride | 70 | 5,774 | £1.4K | +43.7% ▲ |
| Insulin detemir | 70 | 530 | £4.4K | -10.6% ▼ |
| 70 | 232 | £3.6K | +589.7% ▲ | |
| Valproic acid | 69 | 2,970 | £644 | -20.7% ▼ |
| Amantadine hydrochloride | 69 | 2,520 | £676 | +147.7% ▲ |
| Bisacodyl | 67 | 3,793 | £191 | -48.9% ▼ |
| Domperidone | 67 | 4,004 | £87 | +87.8% ▲ |
| Liothyronine sodium | 67 | 5,782 | £19.2K | +214.1% ▲ |
| Letrozole | 66 | 2,464 | £220 | -64.7% ▼ |
| 66 | 2,019 | £5.1K | +67.8% ▲ | |
| Ferrous gluconate | 65 | 1,358 | £43 | +35.9% ▲ |
| Ondansetron hydrochloride | 64 | 3,579 | £1.1K | +31.9% ▲ |
| Dulaglutide | 64 | 324 | £5.9K | -44.2% ▼ |
| Coal tar | 64 | 14.9K | £409 | -12.1% ▼ |
| Haloperidol | 63 | 3,329 | £7.1K | +32.3% ▲ |
| Rivastigmine | 63 | 3,766 | £1.5K | -8.4% ▼ |
| 63 | 730 | £370 | +46.1% ▲ | |
| Ursodeoxycholic acid | 62 | 7,194 | £2.3K | -6.3% ▼ |
| Orlistat | 61 | 5,544 | £1.3K | -26.0% ▼ |
| Mefenamic acid | 61 | 4,440 | £862 | +35.0% ▲ |
| Betamethasone sodium phosphate | 61 | 760 | £167 | +135.5% ▲ |
| 61 | 163 | £1.3K | -10.9% ▼ | |
| Oxytetracycline | 60 | 5,880 | £2.3K | +132.3% ▲ |
| Betamethasone esters | 60 | 3,880 | £417 | -0.5% vs avg |
| 60 | 1,240 | £834 | +82.8% ▲ | |
| 60 | 465 | £1.1K | +310.8% ▲ | |
| Imipramine hydrochloride | 59 | 5,684 | £208 | +131.4% ▲ |
| 59 | 6,725 | £932 | +50.1% ▲ | |
| 58 | 2,040 | £1.4K | +97.4% ▲ | |
| Terbutaline sulphate | 57 | 63 | £497 | +5.1% ▲ |
| Vortioxetine | 57 | 2,856 | £2.7K | -17.9% ▼ |
| 57 | 2,160 | £9.3K | +26.1% ▲ | |
| Desloratadine | 56 | 3,630 | £285 | +94.2% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.